30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Sana Biotechnology Inc (SANA)

Track

The most recent insider trading activity occurred on February 18, 2025, with a proposed sale of 75,000 shares valued at $237,000 by an Officer. Prior transactions include sales and proposed sales by various insiders, including Officers and a Former CFO, throughout late 2024 and early 2025.
Stock chart
Ticker: SANA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
CHRISTIAN HORDO & KATHARINE HORDO
Officer
1 sale — total 237,000 USD
Proposed sale 18 Feb 2025
Value US$2,075,659.73 | Price 343.04 | Shares 33,423
Proposed sale 16 Jan 2025
Value US$570,747.54 | Price 240.73 | Shares 90,701
Sale 8 Jan 2025
Value US$7,260.00 | Price 7.26 | Shares 1,000
Sale 8 Jan 2025
Value US$1,106,559.52 | Price 6.71 | Shares 164,912
Sale 8 Jan 2025
Value US$162,500.00 | Price 6.50 | Shares 25,000
Sale 8 Jan 2025
Value US$611,000.00 | Price 6.11 | Shares 100,000
Proposed sale 16 Dec 2024
Value US$141,750.00 | Price 1.89 | Shares 75,000
Proposed sale 26 Nov 2024
Value US$229,017.50 | Price 2.50 | Shares 91,607
Proposed sale 25 Nov 2024
Value US$64,959.57 | Price 2.50 | Shares 25,933
Proposed sale 21 Oct 2024
Value US$180,807.19 | Price 3.95 | Shares 45,796
Planned sale 25 Sep 2024
Value US$583,170.00 | Price 3.89 | Shares 150,000
Proposed sale 25 Sep 2024
Value US$613,500.00 | Price 4.09 | Shares 150,000
Planned sale 24 Sep 2024
Value US$612,570.00 | Price 4.08 | Shares 150,000
Proposed sale 24 Sep 2024
Value US$613,500.00 | Price 4.09 | Shares 150,000
Sale 8 Mar 2024
Value US$236,300.00 | Price 9.45 | Shares 25,000
Buy 8 Feb 2024
Value US$3,999,996.00 | Price 5.50 | Shares 727,272
Buy 8 Feb 2024
Value US$3,999,996.00 | Price 5.50 | Shares 727,272
Buy 8 Feb 2024
Value US$2,000,003.50 | Price 5.50 | Shares 363,637
Buy 8 Feb 2024
Value US$3,999,996.00 | Price 5.50 | Shares 727,272
Buy 8 Feb 2024
Value US$3,999,996.00 | Price 5.50 | Shares 727,272
Buy 8 Feb 2024
Value US$2,000,003.50 | Price 5.50 | Shares 363,637
Buy 8 Feb 2024
Value US$3,999,996.00 | Price 5.50 | Shares 727,272
Buy 8 Feb 2024
Value US$3,999,996.00 | Price 5.50 | Shares 727,272
Buy 8 Feb 2024
Value US$2,000,003.50 | Price 5.50 | Shares 363,637
Planned sale 15 Dec 2023
Value US$300,097.50 | Price 4.00 | Shares 75,000
Proposed sale 15 Dec 2023
Value US$299,250.00 | Price 3.99 | Shares 75,000
Sale 7 Jun 2023
Value US$142,015.57 | Price 6.24 | Shares 22,760
Sale 7 Jun 2023
Value US$1,105,924.43 | Price 6.24 | Shares 177,240
Proposed sale 7 Jun 2023
Value US$1,981,986.00 | Price 6.39 | Shares 310,170
Proposed sale 7 Jun 2023
Value US$254,514.00 | Price 6.39 | Shares 39,830
Sale 6 Jun 2023
Value US$140,607.11 | Price 6.31 | Shares 22,297
Sale 6 Jun 2023
Value US$1,144,311.21 | Price 6.31 | Shares 181,461
Sale 26 May 2023
Value US$58,093.24 | Price 6.23 | Shares 9,330
Sale 26 May 2023
Value US$452,479.76 | Price 6.23 | Shares 72,670
Sale 25 May 2023
Value US$83,385.33 | Price 6.35 | Shares 13,127
Sale 25 May 2023
Value US$649,480.69 | Price 6.35 | Shares 102,245
Sale 24 May 2023
Value US$259,850.62 | Price 6.57 | Shares 39,580
Sale 24 May 2023
Value US$2,023,985.51 | Price 6.57 | Shares 308,290
Proposed sale 24 May 2023
Value US$598,191.00 | Price 7.01 | Shares 85,334
Proposed sale 24 May 2023
Value US$4,659,309.00 | Price 7.01 | Shares 664,666
Proposed sale 24 May 2023
Value US$598,191.00 | Price 7.01 | Shares 85,334
Buy 21 Mar 2022
Value US$204,400.00 | Price 7.30 | Shares 28,000
Planned sale 18 Feb 2022
Value US$2,091.24 | Price 6.28 | Shares 333
Planned sale 16 Sep 2021
Value US$42,302.00 | Price 26.00 | Shares 1,627
Planned sale 15 Sep 2021
Value US$1,521,754.92 | Price 26.07 | Shares 58,373
Planned sale 10 Sep 2021
Value US$36,925.00 | Price 25.00 | Shares 1,477
Buy 3 Feb 2021
Value US$500,000.00 | Price 25.00 | Shares 20,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-18 2025-02-18 PrS Proposed sale
CHRISTIAN HORDO & KATHARINE HORDO

Officer

Officer
33,423
343.04
US$2,075,660 		33,423 343.04 US$2,075,660
2025-01-16 2025-01-16 PrS Proposed sale
CHRISTIAN HORDO & KATHARINE HORDO

Officer

Officer
90,701
240.73
US$570,748 		90,701 240.73 US$570,748
2025-01-10 2025-01-08 S Sale
3.5
FMR LLC

See Remark 1

Large shareholder
26,324 +21.4%
74.94
US$3,170,391 		26,324 +21.4% 74.94 US$3,170,391
2025-01-10 2025-01-08 S Sale
3.5
FMR LLC

See Remark 1

Large shareholder
164,912 -3.5%
6.71
US$1,106,560 		164,912 -3.5% 6.71 US$1,106,560
2025-01-10 2025-01-08 S Sale
3.5
FMR LLC

See Remark 1

Large shareholder
25,000 -0.5%
6.50
US$162,500 		25,000 -0.5% 6.50 US$162,500
2025-01-10 2025-01-08 S Sale
3.5
FMR LLC

See Remark 1

Large shareholder
100,000 -2.1%
6.11
US$611,000 		100,000 -2.1% 6.11 US$611,000
2024-12-16 2024-12-16 PrS Proposed sale
CHRISTIAN HORDO & KATHARINE HORDO JT TEN

Officer

Officer
75,000
1.89
US$141,750 		75,000 1.89 US$141,750
2024-11-26 2024-11-26 PrS Proposed sale
Hardy Nathan

Former CFO
91,607
2.50
US$229,018 		91,607 2.50 US$229,018
2024-11-25 2024-11-25 PrS Proposed sale
NATHAN HARDY

Former CFO
25,933
2.50
US$64,960 		25,933 2.50 US$64,960
2024-10-21 2024-10-21 PrS Proposed sale
NATHAN HARDY

Officer

Officer
45,796
3.95
US$180,807 		45,796 3.95 US$180,807
2024-09-26 2024-09-25 PlS Planned sale
Mulligan Richard
Non-Executive Director
150,000 -5.3%
3.89
US$583,170 		150,000 -5.3% 3.89 US$583,170
2024-09-25 2024-09-25 PrS Proposed sale
RICHARD MULLIGAN

Director

Non-Executive Director
150,000
4.09
US$613,500 		150,000 4.09 US$613,500
2024-09-26 2024-09-24 PlS Planned sale
Mulligan Richard
Non-Executive Director
150,000 -5.0%
4.08
US$612,570 		150,000 -5.0% 4.08 US$612,570
2024-09-24 2024-09-24 PrS Proposed sale
RICHARD MULLIGAN

Director

Non-Executive Director
150,000
4.09
US$613,500 		150,000 4.09 US$613,500
2024-03-11 2024-03-08 S Sale
3.0
Yang Patrick Y
Non-Executive Director
25,000 -14.3%
9.45
US$236,300 		25,000 -14.3% 9.45 US$236,300
2024-02-12 2024-02-08 B Purchase
3.3
NELSEN ROBERT
Non-Executive Director Large shareholder
727,272 +6.2%
5.50
US$3,999,996 		727,272 +6.2% 5.50 US$3,999,996
2024-02-12 2024-02-08 B Purchase
3.3
NELSEN ROBERT
Non-Executive Director Large shareholder
727,272 +6.2%
5.50
US$3,999,996 		727,272 +6.2% 5.50 US$3,999,996
2024-02-12 2024-02-08 B Purchase
3.3
NELSEN ROBERT
Non-Executive Director Large shareholder
363,637 +3.5%
5.50
US$2,000,004 		363,637 +3.5% 5.50 US$2,000,004
2024-02-12 2024-02-08 B Purchase
CRANDELL KEITH
Large shareholder
727,272 +6.2%
5.50
US$3,999,996 		727,272 +6.2% 5.50 US$3,999,996
2024-02-12 2024-02-08 B Purchase
CRANDELL KEITH
Large shareholder
727,272 +6.2%
5.50
US$3,999,996 		727,272 +6.2% 5.50 US$3,999,996
2024-02-12 2024-02-08 B Purchase
CRANDELL KEITH
Large shareholder
363,637 +3.5%
5.50
US$2,000,004 		363,637 +3.5% 5.50 US$2,000,004
2024-02-12 2024-02-08 B Purchase
ARCH Venture Fund X, L.P.
Large shareholder
727,272 +6.2%
5.50
US$3,999,996 		727,272 +6.2% 5.50 US$3,999,996
2024-02-12 2024-02-08 B Purchase
ARCH Venture Fund X, L.P.
Large shareholder
727,272 +6.2%
5.50
US$3,999,996 		727,272 +6.2% 5.50 US$3,999,996
2024-02-12 2024-02-08 B Purchase
ARCH Venture Fund X, L.P.
Large shareholder
363,637 +3.5%
5.50
US$2,000,004 		363,637 +3.5% 5.50 US$2,000,004
2023-12-18 2023-12-15 PlS Planned sale
Hordo Christian

EVP, Chief Business Officer

Officer
75,000 -8.0%
4.00
US$300,098 		75,000 -8.0% 4.00 US$300,098
2023-12-15 2023-12-15 PrS Proposed sale
CHRISTIAN HORDO & KATHARINE HORDO JT TEN

Officer

Officer
75,000
3.99
US$299,250 		75,000 3.99 US$299,250
2023-06-08 2023-06-07 S Sale
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
22,760 -1.6%
6.24
US$142,016 		22,760 -1.6% 6.24 US$142,016
2023-06-08 2023-06-07 S Sale
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
177,240 -1.6%
6.24
US$1,105,924 		177,240 -1.6% 6.24 US$1,105,924
2023-06-07 2023-06-07 PrS Proposed sale
FLAGSHIP VENTURES FUND V, L.P.

Affiliate
310,170
6.39
US$1,981,986 		310,170 6.39 US$1,981,986
2023-06-07 2023-06-07 PrS Proposed sale
Flagship V Venturelabs RX Fund, L.P.

Affiliate
39,830
6.39
US$254,514 		39,830 6.39 US$254,514
2023-06-08 2023-06-06 S Sale
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
22,297 -1.6%
6.31
US$140,607 		22,297 -1.6% 6.31 US$140,607
2023-06-08 2023-06-06 S Sale
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
181,461 -1.6%
6.31
US$1,144,311 		181,461 -1.6% 6.31 US$1,144,311
2023-05-26 2023-05-26 S Sale
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
9,330 -0.7%
6.23
US$58,093 		9,330 -0.7% 6.23 US$58,093
2023-05-26 2023-05-26 S Sale
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
72,670 -0.7%
6.23
US$452,480 		72,670 -0.7% 6.23 US$452,480
2023-05-26 2023-05-25 S Sale
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
13,127 -0.9%
6.35
US$83,385 		13,127 -0.9% 6.35 US$83,385
2023-05-26 2023-05-25 S Sale
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
102,245 -0.9%
6.35
US$649,481 		102,245 -0.9% 6.35 US$649,481
2023-05-26 2023-05-24 S Sale
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
39,580 -2.7%
6.57
US$259,851 		39,580 -2.7% 6.57 US$259,851
2023-05-26 2023-05-24 S Sale
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
308,290 -2.7%
6.57
US$2,023,986 		308,290 -2.7% 6.57 US$2,023,986
2023-05-24 2023-05-24 PrS Proposed sale
Flagship V Venturelabs RX Fund, L.P.

affiliate
85,334
7.01
US$598,191 		85,334 7.01 US$598,191
2023-05-24 2023-05-24 PrS Proposed sale
FLAGSHIP VENTURES FUND V, L.P.

affiliate
664,666
7.01
US$4,659,309 		664,666 7.01 US$4,659,309
2023-05-24 2023-05-24 PrS Proposed sale
FLAGSHIP VENTURES FUND V, L.P.

affiliate
85,334
7.01
US$598,191 		85,334 7.01 US$598,191
2022-03-22 2022-03-21 B Purchase
3.0
Yang Patrick Y
Non-Executive Director
28,000 +19.1%
7.30
US$204,400 		28,000 +19.1% 7.30 US$204,400
2022-02-23 2022-02-18 PlS Planned sale
MacDonald James J.

EVP & General Counsel

Officer
333 -0.1%
6.28
US$2,091 		333 -0.1% 6.28 US$2,091
2021-09-17 2021-09-16 PlS Planned sale
AGARWAL SUNIL

EVP, Head of Development & CMO

Officer
1,627 -0.1%
26.00
US$42,302 		1,627 -0.1% 26.00 US$42,302
2021-09-17 2021-09-15 PlS Planned sale
AGARWAL SUNIL

EVP, Head of Development & CMO

Officer
58,373 -3.6%
26.07
US$1,521,755 		58,373 -3.6% 26.07 US$1,521,755
2021-09-14 2021-09-10 PlS Planned sale
Hordo Christian

EVP, Chief Business Officer

Officer
1,477 -0.2%
25.00
US$36,925 		1,477 -0.2% 25.00 US$36,925
2023-02-17 2021-02-03 B Purchase
Bilenker Joshua H.
Non-Executive Director
20,000 +inf%
25.00
US$500,000 		20,000 +inf% 25.00 US$500,000
Explore more

More insider trading research around Sana Biotechnology Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America